Loading...

Butterfly Network, Inc.

BFLY-WTNYSE
Healthcare
Medical - Devices
$0.04
$0.01(32.64%)

Butterfly Network, Inc. (BFLY-WT) Financial Performance & Income Statement Overview

Explore the financials of Butterfly Network, Inc. (BFLY-WT), including yearly and quarterly data on income, cash flow, and balance sheets.

Revenue Growth
24.52%
24.52%
Operating Income Growth
48.90%
48.90%
Net Income Growth
45.78%
45.78%
Operating Cash Flow Growth
57.79%
57.79%
Operating Margin
-78.98%
78.98%
Gross Margin
61.97%
61.97%
Net Profit Margin
-71.78%
71.78%
ROE
-30.53%
30.53%
ROIC
-25.73%
25.73%

Butterfly Network, Inc. (BFLY-WT) Income Statement & Financial Overview

Analyze Butterfly Network, Inc.’s BFLY-WT earnings with segmented quarterly and yearly financial statement figures.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$21.23M$22.35M$20.56M$21.49M
Cost of Revenue$7.84M$8.62M$8.33M$8.90M
Gross Profit$13.38M$13.73M$12.23M$12.59M
Gross Profit Ratio$0.63$0.61$0.59$0.59
R&D Expenses$9.92M$8.83M$8.84M$9.41M
SG&A Expenses$21.22M$22.22M$18.96M$20.41M
Operating Expenses$31.14M$31.05M$27.80M$29.21M
Total Costs & Expenses$38.99M$39.24M$36.13M$38.11M
Interest Income$1.65M$997000.00$1.22M$1.29M
Interest Expense-$347000.00$333000.00$319000.00$309000.00
Depreciation & Amortization-$4.16M$2.51M$2.62M$2.63M
EBITDA-$18.47M-$15.37M-$13.93M-$12.75M
EBITDA Ratio-$0.87-$0.69-$0.68-$0.59
Operating Income-$18.47M-$17.31M-$17.25M-$16.63M
Operating Income Ratio-$0.87-$0.77-$0.84-$0.77
Other Income/Expenses (Net)$4.51M-$899000.00$380000.00$1.54M
Income Before Tax-$13.96M-$18.21M-$16.87M-$15.69M
Income Before Tax Ratio-$0.66-$0.81-$0.82-$0.73
Income Tax Expense$7000.00-$110000.00$58000.00$17000.00
Net Income-$13.97M-$18.10M-$16.92M-$15.71M
Net Income Ratio-$0.66-$0.81-$0.82-$0.73
EPS-$0.06-$0.08-$0.08-$0.07
Diluted EPS-$0.06-$0.08-$0.08-$0.07
Weighted Avg Shares Outstanding$234.92M$211.68M$212.77M$211.66M
Weighted Avg Shares Outstanding (Diluted)$234.92M$211.68M$212.77M$211.66M

Over the past four quarters, Butterfly Network, Inc. demonstrated steady revenue growth, increasing from $21.49M in Q2 2024 to $21.23M in Q1 2025. Operating income reached -$18.47M in Q1 2025, maintaining a consistent -87% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$18.47M, reflecting operational efficiency. Net income rose to -$13.97M, with EPS at -$0.06. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;